The global number of COVID-19 cases and deaths has fallen for the sixth week in a row, marking a sharp downward trend in the pandemic. So much so, in fact, that many countries are planning a return to something resembling “normality” by June or July.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in
The close competition to create a vaccine for COVID-19 by the world's leading biopharmaceutical companies has given people a fresh hope that the biggest pandemic of the century will be eventually eradicated. Meanwhile Pfizer and Moderna have recently announced their COVID-19 vaccines are more than 90% effective.